NMDA receptor subunits: function and pharmacology.

Given the growing body of evidence that diverse brain disorders implicate different NMDAR subtypes, such as NR2B in pain or NR3A in white matter injury, there is a growing interest in exploiting the pharmacological heterogeneity of N MDARs for the development of novel NMD AR subtype-selective compounds.